Mirae Asset Global Investments Co., Ltd. Rhythm Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,211 shares of RYTM stock, worth $127,751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,211
Previous 1,820
21.48%
Holding current value
$127,751
Previous $74,000
55.41%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RYTM
# of Institutions
190Shares Held
67.1MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$417 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$390 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$370 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$352 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$224 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.22B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...